Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy

• Published in: World journal of surgical oncology 2023-10, Vol.21 (1), p.1-345, Article 345
• Main Authors: Song, Young, Bae, Myung Il, Han, Dong Woo, Park, Eun Jung, Park, Sujung, Ham, Sung Yeon
• Format: Article
• Language: English
• Subjects: Analysis; Bioelectrical impedance analysis; Bioelectricity; Body composition; Body fat; Body water; Cancer; Cardiac patients; Care and treatment; Chemotherapy; Colorectal cancer; Complications; Diabetes; Fat-free body mass; Gastric cancer; Health aspects; Hospitals; Hydration; Hypertension; Hyperthermic intraperitoneal chemotherapy; Kidney cancer; Medical prognosis; Medical records; Metastases; Metastasis; Morbidity; Mortality; Musculoskeletal system; Nutritional status; Oncology, Experimental; Patient outcomes; Patients; Peritoneum; Postoperative; Prognosis; Proteins; Surgery
• ISSN: 1477-7819; 1477-7819
• DOI: 10.1186/s12957-023-03233-0

Background Bioelectric impedance analysis (BIA)-measured body composition and nutritional status have been used as prognostic indicators in various cancer cohorts. This study investigated whether BIA could provide information on prognosis in peritoneal carcinomatosis patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods We retrospectively analyzed the data of 99 patients with preoperative BIA data among those who underwent CRS and HIPEC. The association between BIA-derived parameters and intraoperative peritoneal cancer index (PCI) score was assessed. Predictive analysis for the occurrence of postoperative morbidities including major complications (Clavien-Dindo classification 3-4) and re-admission within 30 days after surgery as well as 1 year mortality was also performed. Results BIA-derived mineral (r = 0.224, p = 0.027), fat (r = - 0.202, p = 0.048), and total body water (TBW)/fat-free mass (FFM) (r = - 0.280, p = 0.005) showed significant associations with intraoperative PCI score. Lower TBW/FFM was an independent predictor of major postoperative complications (OR 0.047, 95% CI 0.003-0.749, p = 0.031) and re-admission (OR 0.094, 95% CI 0.014-0.657, p = 0.017) within 30 days after surgery. Higher fat mass was also independently associated with a higher risk of major postoperative complications (OR 1.120, 95% CI 1.006-1.248, p = 0.039) and re-admission (OR 1.123, 95% CI 1.024-1.230, p = 0.013). Intraoperative PCI score > 20 (OR 4.489, 95% CI 1.191-16.917, p = 0.027) and re-admission within 30 days after surgery (OR 5.269, 95% CI 1.288-21.547, p = 0.021) independently predicted postoperative 1-year mortality. Conclusions We demonstrate that preoperative BIA-derived TBW/FFM and fat mass were significantly correlated with metastatic extent, assessed by PCI score, in patients with peritoneal carcinomatosis. In addition, BIA-derived TBW/FFM and fat mass showed independent predictability for postoperative 30-day major complications and re-admission in patients undergoing CRS and HIPEC. Our findings suggest that assessment of BIA may improve discrete risk stratification in patients who are planned to receive CRS and HIPEC. Keywords: Bioelectrical impedance analysis, Hyperthermic intraperitoneal chemotherapy, Prognosis